More Resources Are Needed in the Fight on Fraud
We are only recovering a fraction of the billions of dollars being lost to fraud. Whistleblowers are stepping up if the government has the resources to run with their cases.
Pill Talk: Negotiating, Lobbying, and Inflating Drug Prices
From 2000 to 2020, the government increased its spending on prescription drugs by 91 percent, now it's trying to rein in costs.
Kickbacks Come in All Shapes and Sizes
In just the first six months of 2024, the DOJ announced eleven enforcement actions recovering nearly $140 million alleging Anti-Kickback Statute violations.
How Fraudsters Are Taking Advantage – of Medicare Advantage
The money spent on Medicare Advantage could have paid for 4.5 million traditional Medicare beneficiaries for an entire year.
Telehealth: A New Trend in both Healthcare and Healthcare Fraud
Telehealth fraud spread "like wildfire" during the pandemic, and enforcement actions are still being brought against fraudsters.
Private Equity Will See You Now
Private equity has invested more than $1 trillion in healthcare entities in the last decade and in some cases poses a danger to patients and an increase in fraud.
Whistleblowers had tremendous victories in 2023—and their numbers are rising
712 whistleblower False Claims Act cases were filed last year, the highest in almost a decade, and there are other encouraging trends
At Your Service: Government Procurement of Services
The federal government’s procurement of tens of billions of dollars for engineering and technical services is also vulnerable to fraud.
How Much Does a Pharmaceutical Product Cost the Government? It Depends…
The CBO’s complex flow charts, which are supposed to clarify how pricing is determined, are virtually indecipherable to the average consumer.
A Growing Threat to Medical Devices: Cybersecurity Fraud
A growing amount of medical devices are becoming increasingly vulnerable to cybersecurity attacks, rising 59% in just one year.
